<DOC>
	<DOCNO>NCT02948894</DOCNO>
	<brief_summary>Primary aim : The MOSAIC trial aim assess impact mandibular advancement device ( MAD ) Apnea-Hypopnea Index ( AHI ) Asian patient Heart Failure reduce Ejection Fraction ( HFrEF ) obstructive sleep apnea ( OSA ) . The investigator hypothesize AHI 60 % low 3-month treatment MAD sham MAD . Secondary aim : The investigator also aim determine i. interaction ethnicity ( Chinese , Malay , Indians ) effect MAD lower AHI ; ii . effect MAD cardiac remodeling ( LVEDVI assess cardiac magnetic resonance image [ CMR ] ) ; iii . characteristic craniofacial skeletal anatomy ( use con beam compute tomography [ CT ] ) associate OSA Asian patient HFrEF ; iv . association self-reported adherence MAD cardiac remodeling ; v. effect MAD biomarkers HF ( N-terminal pro-B-type natriuretic peptide [ NT-proBNP ] , high sensitivity cardiac troponin T [ h cTnT ] , high-sensitivity C-reactive protein [ hs-CRP ] , ST2 ) ; Rationale : OSA associate incident HF . The investigator study Asian patient body evidence suggest mechanism OSA differ Asians Caucasians . While obesity major contribute factor Caucasians , craniofacial skeletal anatomy ( short mandible , maxilla , cranial base large mandibular volume ) play important role development OSA among Asians . Using cone beam CT , show Asians short mandibular , maxillary , cranial base length great mandibular volume compare Caucasians . Using MAD adjust maxillary-mandibular juxta-positioning maintain patent airway may ethnic-specific approach treat OSA Asians .</brief_summary>
	<brief_title>Mandibular Advancement Device Treatment Obstructive Sleep Apnea Its Impact Cardiac Remodeling</brief_title>
	<detailed_description>The MOSAIC randomize , double-blind , placebo-controlled , cross-over trial conduct National University Health System . It collaboration National University Heart Centre Singapore , Faculty Dentistry , University Medicine Cluster . Apart evaluate effect MAD AHI- conventional measure OSA severity , investigator also explore effect MAD cardiac remodeling . Adverse remodel equates progressive worsen cardiac function , slow reverse remodel goal HF therapy . Ventricular measure include LV end diastolic volume index ( LVEDVI ) proven meaningful surrogate reflect beneficial effect therapeutic agent angiotensin-converting enzyme inhibitor beta-adrenergic block agent remodel process `` hard '' morbid mortal end point . Screening . Patients ( n=200 ) undergo polysomnography con beam CT follow criterion meet : ( ) Asians ( Chinese , Malay Indians ) live Singapore ( ii ) symptomatic HF ( NYHA class II-III ) due ischemic cardiomyopathy , ( iii ) LVEF &lt; 45 % ( determined echocardiography ) ( iv ) clinical stability ≥1 month , ( v ) optimal medical therapy include diuretic , angiotensin-converting enzyme inhibitor angiotensin receptor blocker , beta-blocker . The dos background medication stable ≥1 month . Exclusion criterion : - ( ) know OSA treatment , ( ii ) acute coronary syndrome within precede 3 month , ( iii ) severe valvular heart disease , ( iv ) sustain ventricular arrhythmia , ( v ) stroke residual neurological deficit , ( vi ) contraindication CMR pacemaker cardioverter-defibrillator implant . Overnight Polysomnography perform National University Health System ( NUHS ) Cardiosleep Research Laboratory follow standard laboratory protocol computerize recording system . All sleep study score accord American Academy Sleep Medicine guideline , experienced sleep physician . Apnea define complete cessation airflow last ≥10 hypopnea reduction airflow thoraco-abdominal movement ≥50 % ≥10 s. Apneas classify ( ) obstructive thoraco-abdominal movement present apnea ; ( ii ) central thoraco-abdominal movement absent ; ( iii ) mix thoraco-abdominal movement present absent period airflow cessation . Coned beam CT. To determine specific craniofacial anatomy predict OSA Asians HFrEF , patient ( regardless polysomnography result ) undergo con beam CT craniofacial profiling Faculty Dentistry . Image acquisition perform quiet tidal breathing subject supine neutral head position . Landmarks identify measurement perform previously report . Tongue area measure tracing contour sagittal plane , whereas lateral wall thickness parapharyngeal fat quantify axial plane . To determine tongue volume , tongue limit identify trace manually axial image obtain . Volumetric reconstruction perform determine mandible , tongue , airway volume . Randomization . After initial evaluation , patient find OSA ( estimate prevalence 50 % , n=100 ) AHI ≥ 15 events/hr randomize ( ) MAD follow sham MAD ( non-advanced device ) ( ii ) sham MAD follow MAD , 2-week washout period . A dentist , otherwise involved HF care , open seal envelope time randomization program MAD device accordingly . Each mode maintain 3 month , comprehensive testing ( polysomnography , CMR , biomarker assay ) end 3-month period . The patient would also keep daily record time overnight wear device ( adherence ) . Mandibular Advancement Devices . MADs design improve upper airway configuration prevent collapse alteration jaw tongue position . MADs show randomized trial improve OSA symptom . A significant reduction blood pressure , improvement endothelial reactivity fall plasma NT-pro BNP report MAD treatment . Side effect treatment , pain teeth jaw , generally mild transient . In randomized trial , MAD continuous positive airway pressure therapy find equally effective reduce blood pressure patient moderate-to-severe OSA . Given MADs target mandible mechanically protrude low jaw enlarge upper airway , hypothesize could particularly effective Asian patient . CMR . Imaging perform 1.5T CMR machine phased-array chest coil , breath-hold , gated ECG . A steady-state free-precession sequence use acquire short-axis cine stack LV . Gadolinium administer rapid intravenous bolus first pas perfusion imaging perform . After 15-min delay , contrast-sensitive segment inversion recovery sequence use acquire second stack short-axis image . Post-processing perform use commercially available software . Manual planimetry , perform one observer blind treatment allocation MOSAIC study , use trace epicardial endocardial contour short-axis slice acquire cine stack , LVEDVI measure calculate . Biomarkers . Serum level NT-proBNP , TnT , hs-CRP , ST2 evaluate serially . NT-proBNP release cardiac myocytes response pressure volume overload , tachyarrhythmia hypoxaemia , predominant stimulus end-diastolic wall stress . NT-proBNP provide independent prognostic information disease progression , hospital re-admission mortality . TnT typically use diagnose myocardial infarction , elevate troponin commonly present patient HF . Troponin upper reference limit associate severe HF . Inflammation important mechanism progression HF . In recent study patient HF , prognostic value hs-CRP investigate found mortality rate increase low high hs-CRP quartile . After adjustment confounders , hs-CRP find independent predictor 12-month mortality . ST2 interleukin ( IL ) -1 receptor family member secrete circulation function `` decoy '' receptor IL-33 , inhibit IL-33/ST2 signaling . In patient HF , plasma ST2 strongly associate measure HF severity poor outcome .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Asians ( Chinese , Malay Indians ) live Singapore Symptomatic HF ( NYHA class IIIII ) due ischemic cardiomyopathy LVEF &lt; 45 % ( determined echocardiography ) Clinical stability ≥1 month Optimal medical therapy include diuretic , angiotensinconverting enzyme inhibitor angiotensin receptor blocker , betablocker . The dos background medication stable ≥1 month . Known OSA treatment Acute coronary syndrome within precede 3 month Severe valvular heart disease Sustained ventricular arrhythmia Stroke residual neurological deficit Contraindication CMRsuch pacemaker cardioverterdefibrillator implant .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>